학술논문

Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
Document Type
Letter
Source
In: Clinical and Experimental Allergy. (Clinical and Experimental Allergy, April 2024, 54(4):286-290)
Subject
Language
English
ISSN
13652222
09547894